Back

Effectiveness and safety of bempedoic acid in routine clinical practice: 1-year follow-up snapshot of the MILOS German cohort

26 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Statins, bempedoic acid and ezetimibe: novel findings Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Ioanna Gouni-Berthold

University of Cologne, Cologne (Germany)

6 More presentations in this session

Presentation thumbnail
Strike Early and Strike Strong: application of a strategy comprising first-line combination of high-intensity statins and ezetimibe for patients with acute myocardial infarction in routine practice
Professor F. Schiele (Besancon, FR)
Abstract Slides Video
Presentation thumbnail
The impact of statin intensity on long-term outcomes in elderly patients with acute myocardial infarction who have undergone percutaneous coronary intervention
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial
Associate Professor S. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Improving statins effectiveness by targeting baseline LDL cholesterol in type 2 diabetes mellitus, a systematic review and meta-analysis
Mrs N. Soroush (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Therapeutic gaps in low-density lipoprotein cholesterol management have narrowed over time but remain wide: a wide study of 40,141 acute coronary syndrome patients from 2016 to 2021
Doctor G. Tan (Shatin, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Statins, bempedoic acid and ezetimibe: novel findings

The Event

Event poster

ESC Congress 2023

26 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Real-world effectiveness of bempedoic acid therapy on the reduction of low-density lipoprotein cholesterol levels in Germany
30 August 2025
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with and without type 2 diabetes mellitus: a subgroup analysis from the CHOLINET Registry
30 August 2025
thumbnail
Congress Presentation
The effect of implementing a guideline-based approach to achieve target LDL-C levels in very high risk patients. The PENELOPE study one year follow-up results.
28 August 2023
thumbnail
Congress Session
HOT LINE SESSION 8
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources